$38.17
1.14% day before yesterday
Nasdaq, Dec 26, 10:00 pm CET

Phibro Animal Health Corporation Class A Stock price

$38.17
-5.06 11.70% 1M
+13.05 51.95% 6M
+17.17 81.76% YTD
+16.49 76.06% 1Y
+24.27 174.60% 3Y
+19.00 99.11% 5Y
+7.92 26.18% 10Y
+21.17 124.53% 20Y
Nasdaq, Closing price Fri, Dec 26 2025
+0.43 1.14%

Key metrics

Basic
Market capitalization
$1.5b
Enterprise Value
$2.2b
Net debt
$657.7m
Cash
$85.3m
Shares outstanding
40.5m
Valuation (TTM | estimate)
P/E
23.0 | 13.7
P/S
1.1 | 1.0
EV/Sales
1.6 | 1.5
EV/FCF
64.4
P/B
5.0
Dividends
DPS
$0.48
Yield 1Y | 5Y
1.3% | 2.6%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
40.3% | 69.9%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$1.4b | $1.5b
EBITDA
$218.0m | $239.5m
EBIT
$168.5m | $192.8m
Net Income
$67.8m | $113.1m
Free Cash Flow
$34.3m
Growth (TTM | estimate)
Revenue
33.7% | 15.3%
EBITDA
77.7% | 30.9%
EBIT
95.1% | 40.3%
Net Income
289.5% | 134.4%
Free Cash Flow
-15.7%
Margin (TTM | estimate)
Gross
31.9%
EBITDA
15.6% | 16.0%
EBIT
12.0%
Net
4.9% | 7.6%
Free Cash Flow
2.5%
Financial Health
Equity Ratio
21.0%
Return on Equity
16.9%
ROCE
15.1%
ROIC
10.8%
Debt/Equity
2.4
More
EPS
$1.7
FCF per Share
$0.8
Short interest
5.3%
Employees
2k
Rev per Employee
$670.0k
Show more

Is Phibro Animal Health Corporation Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Phibro Animal Health Corporation Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Phibro Animal Health Corporation Class A forecast:

1x Buy
11%
4x Hold
44%
4x Sell
44%

Analyst Opinions

9 Analysts have issued a Phibro Animal Health Corporation Class A forecast:

Buy
11%
Hold
44%
Sell
44%

Financial data from Phibro Animal Health Corporation Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,400 1,400
34% 34%
100%
- Direct Costs 953 953
33% 33%
68%
447 447
36% 36%
32%
- Selling and Administrative Expenses 278 278
15% 15%
20%
- Research and Development Expense - -
-
-
218 218
78% 78%
16%
- Depreciation and Amortization 49 49
36% 36%
4%
EBIT (Operating Income) EBIT 169 169
95% 95%
12%
Net Profit 68 68
290% 290%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Phibro Animal Health Corporation Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Phibro Animal Health Corporation Class A Stock News

Neutral
Business Wire
9 days ago
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (the “Company” or “Phibro”) today announced a leadership transition that will support the Company's continued growth and long-term strategic direction. At the end of this fiscal year, effective July 1, 2026, Jack Bendheim, current Chairman, Chief Executive Officer and President of Phibro will take on a new manageria...
Neutral
Seeking Alpha
about 2 months ago
Phibro Animal Health Corporation ( PAHC ) Q1 2026 Earnings Call November 6, 2025 9:00 AM EST Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman, President & CEO Larry Miller - Chief Operating Officer Daniel Bendheim - Executive VP of Corporate Strategy & Director Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Ekaterina Knyazk...
Neutral
Business Wire
about 2 months ago
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2025 and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended September 30, 2025 (compared to the three months ended September 30, 2024) Net sales of $363.9 milli...
More Phibro Animal Health Corporation Class A News

Company Profile

Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Head office United States
CEO Jack Bendheim
Employees 1,940
Founded 1946
Website www.pahc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today